All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis.
Authors: Aymerich C; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain. aymerich.claudia@gmail.com.; Biobizkaia Health Research Institute, Barakaldo, Spain. aymerich.claudia@gmail.com.; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain. aymerich.claudia@gmail.com.; University of the Basque Country, UPV/EHU, Leioa, Spain. aymerich.claudia@gmail.com., Salazar de Pablo G; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Child and Adolescent Mental Health Services, South London and Maudsley NHS Foundation Trust, London, UK.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Madrid, Spain., Pacho M; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain., Pérez-Rodríguez V; South London and Maudsley NHS Foundation Trust (Southwark CAMHS), London, UK., Bilbao A; Osakidetza Basque Health Service, Basurto University Hospital, Research and Innovation Unit, Bilbao, Spain.; Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Bilbao, Spain., Andrés L; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain., Pedruzo B; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain.; Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain.; Kronikgune Health Services Research Institute, Barakaldo, Spain., Castillo-Sintes I; Osakidetza Basque Health Service, Basurto University Hospital, Research and Innovation Unit, Bilbao, Spain.; Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Bilbao, Spain.; Kronikgune Health Services Research Institute, Barakaldo, Spain., Aranguren N; Osakidetza Basque Health Service, Basurto University Hospital, Research and Innovation Unit, Bilbao, Spain., Fusar-Poli P; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), London, UK.; Outreach and Support in South London (OASIS) service, South London and Maudsley NHS Foundation Trust, London, UK., Zorrilla I; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain.; University of the Basque Country, UPV/EHU, Leioa, Spain.; Bioaraba, Mental Health and Childhood Research Group, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Araba University Hospital, Psychiatry Department, Vitoria-Gasteiz, Spain., González-Pinto A; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain.; University of the Basque Country, UPV/EHU, Leioa, Spain.; Bioaraba, Mental Health and Childhood Research Group, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Araba University Hospital, Psychiatry Department, Vitoria-Gasteiz, Spain., González-Torres MÁ; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain.; Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain.; University of the Basque Country, UPV/EHU, Leioa, Spain., Catalán A; Department of Psychiatry, Basurto University Hospital, Bilbao, Spain.; Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERSAM. Centro Investigación Biomédica en Red de Salud Mental, Madrid, Spain.; University of the Basque Country, UPV/EHU, Leioa, Spain.; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Source: Molecular psychiatry [Mol Psychiatry] 2025 Jan; Vol. 30 (1), pp. 263-271. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Journal Article; Systematic Review; Meta-Analysis; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5578
DOI:10.1038/s41380-024-02694-3